Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Nemaura Medical Inc. NMRD

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Positioned to Benefit from Growth in CGM Market

Posted on December 13, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD) has developed a platform to monitor multiple chemicals in the blood without needles, replacing traditional invasive methods of diagnosis and health care observations. With the global continuous glucose monitoring (“CGM”) devices market expected to reach $19.04 … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Initial Shipment of CGM Devices to MySugarWatch Licensee

Posted on December 7, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that it has completed its initial shipment of sugarBEAT(R) continuous glucose monitor (“CGM”) devices to … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

Nemaura Medical Inc. (NASDAQ: NMRD) Helping Diabetic Individuals Safeguard Themselves From COVID-19

Posted on December 7, 2021 by MissionIR

1 in 8 adults are forecast to suffer from diabetes by 2024, with over 1 in 10 deaths in 2021 a direct result of the disease As many as 40% of Covid-19 related fatalities in the US also suffered from … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Benzinga Global Small Cap Conference

Posted on November 30, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that its CEO Faz Chowdhury, Ph.D., will present at the Benzinga Global Small Cap Conference. … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

Nemaura Medical Inc. (NASDAQ: NMRD) Offers ‘First-of-a-Kind’ Device in Growing CGM Market

Posted on November 18, 2021 by MissionIR

The global continuous glucose monitoring devices market size is expected to reach $19.04 billion in 2028 The increasing prevalence of diabetes, rising focus on preventive care are significant factors in the steady revenue growth Nemaura Medical’s sugarBEAT device allows individuals to make … Continue reading →

Posted in Nemaura Medical Inc. NMRD, Small Cap News | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2 2022 Financial, Business Report

Posted on November 15, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, has reported its financial and business updates for the second quarter of FY2022, the period ended Sept. 30, … Continue reading →

Posted in MissionIRNewsBreaks, Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Extending Proprietary Technology, Programs Beyond Traditional Diabetes Market

Posted on November 9, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD), a cutting-edge medical technology company, recently conducted the beta launch of MiBoKo, a new proprietary metabolic health program designed to utilize a non-invasive glucose sensor and an AI-based mobile application. The MiBoKo application is designed to … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Diabetes Technology Society Conference

Posted on November 4, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD)CEO Faz Chowdhury, PhD, will be presenting at annual meeting of the Diabetes Technology Society. The two-day meeting is slated for Nov. 5–6, 2021, with virtual workshops on Thursday, Nov. 4; Chowdury’s presentation is scheduled for Nov. … Continue reading →

Posted in MissionIRNewsBreaks, Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Stands Distinct in Patient Support

Posted on October 28, 2021 by MissionIR

Nemaura Medical (NASDAQ: NMRD), a company focused on providing digital and glucose monitoring solutions for patients dealing with diabetes, pays close attention to essential information and research that impacts the successful implementation of its solutions. Recently, the company tweeted about … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment

Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) Target Diabetes Tech

Posted on October 26, 2021 by MissionIR

The world’s largest and most powerful tech companies –Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) – are targeting an opportunity in health care that’s just too big to ignore – diabetes. Almost a third of the entire … Continue reading →

Posted in Nemaura Medical Inc. NMRD | Leave a comment